OR WAIT null SECS
A look at the latest industry news as of May 2008.
• After spending the past 10 years in a business development role at Essential Group (Gurnee, IL), Caroline Redeker was promoted to vice president of business development and will now manage customer relationships and the sales and marketing of Essential's CRO and subject recruitment services.
• As ClinPhone's (Nottingham, UK) new director of product management–data management solutions, Paula McHale will provide insight to product strategy for DataLabs, the company's EDC software, as well as ClinPhone's combined EDC-IVR/IWR product.
• Having departed from his previous position as AstraZeneca's (London, UK) regional medical director–Asia Pacific, Dr. Ross Horsburgh will now oversee Kendle's (Cincinnati, OH) Asia/Pacific operations as the company's new vice president of global clinical development–Asia/Pacific. Additionally, Kendle recently welcomed Philip Davies—former director of global exploratory and program phase medical operations for Eli Lilly (Indianapolis, IN)—as vice president–Phase I.
Dr. Ross Horsburgh
• Inclinix (Wilmington, NC) made some changes to its executive management team. Steven Agnoff began working as vice president of marketing and product management; Daniel Marks joined the company as vice president of corporate development; Jeffrey Bagshaw has taken on the role of senior vice president of sales; and Susan Jalbert comes to Inclinix as director of North American sales.
• Due to increased business at Criterium's (Saratoga Springs, NY) India office, the company hired a few new staff members, including Dr. Vikrant Korde, a clinical research associate; Swapnil Shewale, a project assistant; and Nikhil Kajale, a clinical research associate. Furthermore, Garima Singh, formerly a project trainee for Criterium India, was promoted to clinical research associate, and Susan Blackburn has joined the NY headquarters as clinical data liaison.
• Dr. Barry Anderson brings his 20 years of experience in cancer research and treatment to Theradex (Princeton, NJ) as the company's vice president of clinical research affairs.
• Parexel's (Boston, MA) medical communications services business found a new vice president and general manager in Jacque Fisher, who will be responsible for leading a team in translating scientific information into integrated communications, as well as fulfilling client management and advisory roles.
• CardioVascular BioTherapeutics (Las Vegas, NV) hired Dr. Nabil Dib—director of cardiovascular research at AZ-based Catholic Healthcare West's Chandler Regional Medical Center and Mercy Gilbert Medical Center, and assistant professor of medicine and director of clinical cardiovascular cell therapy at the University of California, San Diego—as the principal investigator in a Phase II coronary heart disease study.
• With more than 12 years of medical photographic experience, Holly Smith will now serve as director of Profect Medical Technologies' (Brewster, NY) new clinical imaging services division.
• Robert Gundel, who most recently worked as chief scientific officer for Arius Research (Toronto, Canada), is Elusys Therapeutics' (Pine Brook, NJ) new vice president of research.
• ACM-Pivotal increased staff at its UK and U.S. sites, located in York, UK, and Rochester, NY. In the UK, Helen Jenkinson is senior clinical laboratory scientist, Laura Williams is senior project manager, Dean Thompson is logistics manager, and Andrew Botham is a senior scientist, while Chris Ellis and Shirley Macnamara received promotions to head of operations and head of business development, respectively. In the United States, Greg Grinstead is lead toxicologist, Tracy Hendershott is manager of global expansion, and Paul Herasimchuk is head of the data management team.
• Premier Research Group (Philadelphia, PA) recently welcomed Sebastien Duval—who previously had a senior business development role with CIT (Evreux, France)—as a business development director based in France.
• Carl Peck, founding director of the Center for Drug Development Science at the University of California, San Francisco, will now have a place on the Simcyp (Sheffield, UK) Scientific Advisory Board.